Correlation Between Valens and Apogee Therapeutics,
Can any of the company-specific risk be diversified away by investing in both Valens and Apogee Therapeutics, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Valens and Apogee Therapeutics, into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Valens and Apogee Therapeutics, Common, you can compare the effects of market volatilities on Valens and Apogee Therapeutics, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Valens with a short position of Apogee Therapeutics,. Check out your portfolio center. Please also check ongoing floating volatility patterns of Valens and Apogee Therapeutics,.
Diversification Opportunities for Valens and Apogee Therapeutics,
0.15 | Correlation Coefficient |
Average diversification
The 3 months correlation between Valens and Apogee is 0.15. Overlapping area represents the amount of risk that can be diversified away by holding Valens and Apogee Therapeutics, Common in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Apogee Therapeutics, and Valens is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Valens are associated (or correlated) with Apogee Therapeutics,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Apogee Therapeutics, has no effect on the direction of Valens i.e., Valens and Apogee Therapeutics, go up and down completely randomly.
Pair Corralation between Valens and Apogee Therapeutics,
Considering the 90-day investment horizon Valens is expected to under-perform the Apogee Therapeutics,. In addition to that, Valens is 1.15 times more volatile than Apogee Therapeutics, Common. It trades about -0.04 of its total potential returns per unit of risk. Apogee Therapeutics, Common is currently generating about -0.02 per unit of volatility. If you would invest 4,840 in Apogee Therapeutics, Common on August 31, 2024 and sell it today you would lose (370.00) from holding Apogee Therapeutics, Common or give up 7.64% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Valens vs. Apogee Therapeutics, Common
Performance |
| Timeline |
| Valens |
| Apogee Therapeutics, |
Valens and Apogee Therapeutics, Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Valens and Apogee Therapeutics,
The main advantage of trading using opposite Valens and Apogee Therapeutics, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Valens position performs unexpectedly, Apogee Therapeutics, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Apogee Therapeutics, will offset losses from the drop in Apogee Therapeutics,'s long position.The idea behind Valens and Apogee Therapeutics, Common pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.| Apogee Therapeutics, vs. In8bio Inc | Apogee Therapeutics, vs. Cue Biopharma | Apogee Therapeutics, vs. Tff Pharmaceuticals | Apogee Therapeutics, vs. Lantern Pharma |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Top Crypto Exchanges module to search and analyze digital assets across top global cryptocurrency exchanges.
Other Complementary Tools
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. |